Controlled release of curcumin from poly(HEMA-MAPA) membrane
Source abstract
Abstract
In this work, poly(HEMA-MAPA) membranes were prepared by UV-polymerization technique. These membranes were characterized by SEM, FTIR, and swelling studies. Synthesized membranes had high porous structure. These membranes were used for controlled release of curcumin which is already used as folk remedy and used as drug for some certain diseases and cancers. Curcumin release was investigated for various pHs and temperatures. Optimum drug release yield was found to be as 70% at pH 7.4 and 37 °C within 2 h period. Time-depended release of curcumin was also investigated and its slow release from the membrane demonstrated within 48 h.
Source: openalex_inverted_index · Quality: baseline
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Advancements in Transdermal Drug Delivery · Nanoparticle-Based Drug Delivery
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
,
References (33)
Show source-provided references
1. Aggarwal BB, Kumar A, Bharti AC. 2003. Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23:363–398.
2. 10.1002/mabi.20040023010.1002/mabi.200400230 ↗
3. 10.1016/j.canlet.2008.03.02510.1016/j.canlet.2008.03.025 ↗
4. 10.1016/j.bcp.2008.08.00810.1016/j.bcp.2008.08.008 ↗
5. 10.1016/S0032-9592(00)00289-210.1016/S0032-9592(00)00289-2 ↗
6. 10.1016/S0021-9673(97)01079-010.1016/S0021-9673(97)01079-0 ↗
7. 10.1016/0021-9673(92)85253-P10.1016/0021-9673(92)85253-P ↗
8. Bhardwaj A, Kumar L, Mehta S, Mehta A. 2015. Stimuli-sensitive systems-an emerging delivery system for drugs. Artif Cell Blood Sub. 43:299–310.
9. 10.1016/S0927-7765(98)00027-710.1016/S0927-7765(98)00027-7 ↗
10. 10.1016/S0376-7388(97)00172-510.1016/S0376-7388(97)00172-5 ↗
11. 10.1016/S0009-2509(96)00426-510.1016/S0009-2509(96)00426-5 ↗
12. 10.1016/0021-9673(94)00725-X10.1016/0021-9673(94)00725-X ↗
13. 10.1007/s00018-008-7452-410.1007/s00018-008-7452-4 ↗
14. 10.1016/j.canlet.2007.03.00510.1016/j.canlet.2007.03.005 ↗
15. 10.1016/0169-409X(93)90027-210.1016/0169-409X(93)90027-2 ↗
16. 10.1016/0021-9673(91)80021-810.1016/0021-9673(91)80021-8 ↗
17. 10.1016/S0376-7388(96)00328-610.1016/S0376-7388(96)00328-6 ↗
18. 10.1016/0376-7388(96)00054-310.1016/0376-7388(96)00054-3 ↗
19. 10.1002/(SICI)1097-4628(19961121)62:8<1153::AID-APP3>3.0.CO;2-H10.1002/(SICI)1097-4628(19961121)62:8<1153::AID-APP3>3.0.CO;2-H ↗
20. 10.1126/science.221849410.1126/science.2218494 ↗
21. Langer R. 1994. Immobilization biotechnology and drug delivery. Artif Cell Blood Sub Biotechnol. 22:15–17.
22. 10.1016/0021-9673(92)80227-L10.1016/0021-9673(92)80227-L ↗
23. 10.1016/j.copbio.2003.10.00710.1016/j.copbio.2003.10.007 ↗
24. 10.1016/j.seppur.2007.07.03710.1016/j.seppur.2007.07.037 ↗
25. Park H, Park K. 1999. Smart hydrogels. In: Salamone JC, Ed. Concise Polymeric Materials Encyclopedia. Boca Raton, FL: CRC Press, pp. 1476–1478.
26. 10.1016/j.nano.2011.05.01610.1016/j.nano.2011.05.016 ↗
27. 10.1016/j.biotechadv.2014.04.00410.1016/j.biotechadv.2014.04.004 ↗
28. 10.1016/j.addr.2012.09.02410.1016/j.addr.2012.09.024 ↗
29. 10.1016/S0021-9673(96)00894-110.1016/S0021-9673(96)00894-1 ↗
30. Sharma A, Garg T, Aman A, Panchal K, Sharma R, Kumar S, Markandeywar T. 2016. Nanogel – an advanced drug delivery tool: current and future. Artif Cell Blood Sub. 44:165–177.
31. 10.1016/j.ejca.2005.05.00910.1016/j.ejca.2005.05.009 ↗
32. 10.1016/S0376-7388(97)00011-210.1016/S0376-7388(97)00011-2 ↗
33. 10.1016/0169-409X(93)90028-310.1016/0169-409X(93)90028-3 ↗